Passive smoke in workplace increases lung cancer riskFebruary 01, 2007An analysis of nearly two dozen studies confirms the association between passive smoke in the workplace and an increased risk of lung cancer, according to a report in the American Journal of Public Health. The research, led by University of Illinois at Chicago epidemiologist Leslie Stayner, is posted online and will appear in the March print issue of the journal. Stayner and colleagues conducted a statistical analysis combining data from 22 studies evaluating workplace smoking exposure and lung cancer risk. They also analyzed workers' level and duration of exposure to passive smoke and their risk of lung cancer.
The researchers found a 24 percent increase in lung cancer risk among people exposed to passive smoke in the workplace. Workers who were highly exposed had a 100 percent increased (or doubled) risk of lung cancer, and workers with a long history, or duration, of exposure to passive smoke had a 50 percent increased risk. "We believe this provides the strongest evidence to date of the relationship between workplace environmental tobacco smoke and lung cancer," said Stayner, professor and director of epidemiology and biostatistics at the UIC School of Public Health, and lead author of the study. The research, Stayner said, has important policy implications for cities and states that have not yet legislated smoking bans in bars and restaurants where there are high levels of environmental smoke. University of Illinois at Chicago | |||||||||||||||||||||
|
Related Lung Cancer News Articles African-Americans have unique lung cancer risks from chronic obstructive pulmonary disease Scientists at the M.D. Anderson Cancer Center have developed a risk prediction assessment for lung cancer specifically for African Americans that suggests a greater risk from chronic obstructive pulmonary disease (COPD). Breaking the 'mucus barrier' with a new drug delivery system Chemical engineers from Johns Hopkins University have broken the "mucus barrier," engineering the first drug-delivery particles capable of passing through human mucus - regarded by many as nearly impenetrable - and carrying medication that could treat a range of diseases. Those conditions include lung cancer, cervical cancer and cystic fibrosis, the research noted in a presentation scheduled for the 236th National Meeting of the American Chemical Society. Newly detected air pollutant mimics damaging effects of cigarette smoke A previously unrecognized group of air pollutants could have effects remarkably similar to harmful substances found in tobacco smoke, Louisiana scientists are reporting in a study scheduled for presentation today at the 236th National Meeting of the American Chemical Society. Targeted radiation therapy can control limited cancer spread Precisely targeted radiation therapy can eradicate all evidence of disease in selected patients with cancer that has spread to only a few sites, suggests the first published report from an ongoing clinical trial. Experimental chemotherapy regimen shows promise in treating advanced lung cancer A combination of chemotherapy agents that have been tested in other tumor types appears to be a promising alternative to standard treatment for advanced non-small cell lung cancer, according to a report in the August 15 issue of Clinical Cancer Research, a journal of the American Association for Cancer Research. If your first cigarette gave you a buzz and you now smoke, a gene may be to blame Anyone who has ever tried smoking probably remembers that first cigarette vividly. For some, it brought a wave of nausea or a nasty coughing fit. For others, those first puffs also came with a rush of pleasure or "buzz." Gene panel predicts lung cancer survival, study finds Researchers from four leading cancer centers have confirmed that an analysis involving a panel of genes can be used to predict which lung cancer patients will have the worst survival. The finding could one day lead to a test that would help determine who needs more aggressive treatment. Vitamin A pushes breast cancer to form blood vessel cells Researchers at Georgetown University Medical Center have discovered that vitamin A, when applied to breast cancer cells, turns on genes that can push stem cells embedded in a tumor to morph into endothelial cells. These cells can then build blood vessels to link up to the body's blood supply, promoting further tumor growth. Patients unaware of link between smoking and bladder cancer Even though cigarette smoking accounts for up to half of all bladder cancer cases, few people are aware of the connection - including more than three-quarters of patients who have bladder cancer. New oral angiogenesis inhibitor offers potential nontoxic therapy for a wide range of cancers The first oral, broad-spectrum angiogenesis inhibitor, specially formulated through nanotechnology, shows promising anticancer results in mice, report researchers from Children's Hospital Boston. More Lung Cancer News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||